LGT Fund Management Co Ltd. Cuts Holdings in Merck & Co., Inc. $MRK - MarketBeat
LGT Fund Management Co Ltd. Cuts Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co Company News
Girding against Keytruda cliff, Merck splits oncology into standalone business unit - Fierce Pharma
Girding against Keytruda cliff, Merck splits oncology into standalone business unit Fierce Pharma
LGT Group Foundation Sells 72,228 Shares of Merck & Co., Inc. $MRK - MarketBeat
LGT Group Foundation Sells 72,228 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck to create separate cancer division as Keytruda patent loss looms - Reuters
Merck to create separate cancer division as Keytruda patent loss looms Reuters
Russell Investments Group Ltd. Sells 256,688 Shares of Merck & Co., Inc. $MRK - MarketBeat
Russell Investments Group Ltd. Sells 256,688 Shares of Merck & Co., Inc. $MRK MarketBeat
Vinva Investment Management Ltd Purchases 50,206 Shares of Merck & Co., Inc. $MRK - MarketBeat
Vinva Investment Management Ltd Purchases 50,206 Shares of Merck & Co., Inc. $MRK MarketBeat
Rathbones Group PLC Has $34.35 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Rathbones Group PLC Has $34.35 Million Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Position Trimmed by HUB Investment Partners LLC - MarketBeat
Merck & Co., Inc. $MRK Position Trimmed by HUB Investment Partners LLC MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Grantham Mayo Van Otterloo & Co. LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Grantham Mayo Van Otterloo & Co. LLC MarketBeat
Modern Wealth Management LLC Has $2.83 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Modern Wealth Management LLC Has $2.83 Million Position in Merck & Co., Inc. $MRK MarketBeat
Korea Investment CORP Sells 198,111 Shares of Merck & Co., Inc. $MRK - MarketBeat
Korea Investment CORP Sells 198,111 Shares of Merck & Co., Inc. $MRK MarketBeat
Blair William & Co. IL Has $68.18 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Blair William & Co. IL Has $68.18 Million Stake in Merck & Co., Inc. $MRK MarketBeat
Heritage Wealth Advisors Acquires 24,697 Shares of Merck & Co., Inc. $MRK - MarketBeat
Heritage Wealth Advisors Acquires 24,697 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Edgar Lomax Co. VA - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Edgar Lomax Co. VA MarketBeat
Natixis Advisors LLC Has $193.90 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Natixis Advisors LLC Has $193.90 Million Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by DKRT Investments Corp. - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by DKRT Investments Corp. MarketBeat
Merck & Co., Inc. $MRK Holdings Cut by LOM Asset Management Ltd - MarketBeat
Merck & Co., Inc. $MRK Holdings Cut by LOM Asset Management Ltd MarketBeat
GW&K Investment Management LLC Has $23.76 Million Position in Merck & Co., Inc. $MRK - MarketBeat
GW&K Investment Management LLC Has $23.76 Million Position in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas MarketBeat
Orion Porfolio Solutions LLC Has $9.65 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Orion Porfolio Solutions LLC Has $9.65 Million Stock Position in Merck & Co., Inc. $MRK MarketBeat
Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine - Business Wire
Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine Business Wire
Merck Vaccine Sales Drop as US Declines Strike Another Pharma - BioSpace
Merck Vaccine Sales Drop as US Declines Strike Another Pharma BioSpace
Miramar Capital LLC Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Miramar Capital LLC Grows Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Victory Capital Management Inc. Has $397.27 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Victory Capital Management Inc. Has $397.27 Million Stake in Merck & Co., Inc. $MRK MarketBeat
Our Q3 2025 financial results - Merck.com
Our Q3 2025 financial results Merck.com
Merck to lay off around 150 employees at US site amid slump in Gardasil sales - Reuters
Merck to lay off around 150 employees at US site amid slump in Gardasil sales Reuters
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline - BioSpace
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline BioSpace
Merck executes its own Brexit, moving all R&D operations out of UK - Fierce Biotech
Merck executes its own Brexit, moving all R&D operations out of UK Fierce Biotech
Merck's 2026 outlook clouds upbeat fourth-quarter results - Reuters
Merck's 2026 outlook clouds upbeat fourth-quarter results Reuters
Our Q2 2025 financial results - Merck.com
Our Q2 2025 financial results Merck.com
Merck & Co to cut 6000 jobs, Moderna to cut around 500 - Chemistry World
Merck & Co to cut 6000 jobs, Moderna to cut around 500 Chemistry World
Merck plans spending shift to boost business beyond Keytruda - BioPharma Dive
Merck plans spending shift to boost business beyond Keytruda BioPharma Dive
Merck to invest $3 billion in Elkton expansion, adding up to 500 jobs in Shenandoah Valley - Virginia Mercury
Merck to invest $3 billion in Elkton expansion, adding up to 500 jobs in Shenandoah Valley Virginia Mercury
Merck & Co. targets $3B in cost savings, including from job cuts - FirstWord Pharma
Merck & Co. targets $3B in cost savings, including from job cuts FirstWord Pharma
As vaccines industry struggles, Merck's adult pneumococcal shot Capvaxive off to strong start - Fierce Pharma
As vaccines industry struggles, Merck's adult pneumococcal shot Capvaxive off to strong start Fierce Pharma
Merck posts higher third-quarter sales as Keytruda offsets drop in HPV vaccine - Reuters
Merck posts higher third-quarter sales as Keytruda offsets drop in HPV vaccine Reuters
Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 - Fierce Pharma
Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 Fierce Pharma
JPM26: Confident Merck Sees Growth Through Keytruda Loss of Exclusivity - BioSpace
JPM26: Confident Merck Sees Growth Through Keytruda Loss of Exclusivity BioSpace
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees - BioSpace
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees BioSpace
Bahl & Gaynor Inc. Sells 1,406,091 Shares of Merck & Co., Inc. $MRK - MarketBeat
Bahl & Gaynor Inc. Sells 1,406,091 Shares of Merck & Co., Inc. $MRK MarketBeat